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KSENOÖSTROJENLERİN HÜCRE İSKELET PROTEİNLERİ 
ÜZERİNDEKİ TOKSİK ETKİLERİ 
ÖZET 
Ksenoöstrojenler endojen hormonları taklit edebilir ya da endokrin prosesleri 
etkileyebilirler ve endokrin bozucu olarak adlandırılırlar. Ksenoöstrojenlerin yan 
etkileri çok sayıda gelişimsel anomalileri kapsar. Bu çalışmanın konusu olan 
Bisphenol A (BPA) bir endokrin bozucudur. BPA polikarbonat, epoksi ve diğer 
rezinlerin monomeridir. Polikarbonatlar geri dönüşümlü içecek kapları, biberonlar, 
plastik yiyecek eşyaları ve plastik depolama kapları gibi çeşitli tüketici ürünlerinin 
yapımında kullanılır. Epoksi gıda endüstrisinde konserve kutuların kaplamalarında 
ve dişçilikte güçlendirici materyallerde kullanılmaktadır. BPA bu kaynaklardan açığa 
çıkarak insanlar ve doğal hayatın maruz kaldığı çevresel bir toksik ajan oluşturur. 
BPA reprodüktif sistem anomalilerine neden olmaktadır ve çeşitli sistemler üzerinde 
de birçok yan etkisi bulunmaktadır. BPA’nın hücrede iğ mikrotubulleri, mikrotubul-
ilişkili proteinleri, kinetokorları, sentromer, sentrozom ve sentriolleri ve DNA’yı 
hedef aldığı önerilmektedir.  
Hücre iskeleti hücreye düzgün şekil ve uygun yapı veren bir filament ağıdır. 
Ökaryotik hücrelerde üç çeşit filament bulunmaktadır, ara filamentler, mikrotubuller 
ve aktin filamentleri. Mikrotubul polimerizasyon ve depolymerizasyon dinamikleri 
gerek bölünen gerekse bölünmeyen hücrelerde normal hücresel fonksiyonun ve 
morfolojilerin sağlanmasında çok önemli rol oynarlar. 
Bu çalışmada BPA’nın mikrotubuller üzerindeki etkileri araştırıldı. Mikrotubul 
proteinleri taze dana beyninden iki devir polimerizasyon ve depolimerizasyon 
metoduyla elde edildi. BPA’nın mikrotubul polimerizasyon ve depolimerizasyon 
özellikleri üzerindeki etkilerini incelemek amacıyla sedimentasyon deneyleri, 
floresans spektroskopi ve elektron mikroskopi metodları gerçekleştirildi.  
BPA mikrotubul polimerizasyonunu inhibe etti ve taksolle-stabilize edilmiş 
mikrotubulleri depolimerize etti. Elektron mikrograflarında BPA’nın 
depolimerizasyon ve çözülmeyle tutarlı, gevşek ve spiral gibi farklı mikrotubul 
yapılarına neden olduğu gözlendi. Sonuçlar ayrıca BPA’nın mikrotubuller üzerindeki 
etkisini mikrotubul-ilişkili proteinler aracılığıyla gösterdiğini öne sürmektedir. 
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THE TOXIC EFFECTS OF XENOESTROGENS ON CYTOSKELETAL 
PROTEINS 
SUMMARY 
Xenoestrogens can mimic endogenous hormones or interfere with endocrine 
processes hence they are called “endocrine disrupters”. Adverse effects of 
xenoestrogens include a number of developmental abnormalities. Bisphenol A (BPA) 
which is the subject of this study is an endocrine disrupter. BPA is monomers of 
polycarbonate, epoxy and other resins. Polycarbonates are used in a variety of 
consumer products such as returnable beverage containers, infant feeding bottles, 
plastic dinnerware, and plastic storage containers. Epoxy is used in coating of cans in 
the food industry and in restorative materials used in dentistry. BPA is an 
environmental toxicant since it can be released from these sources, resulting in 
human and wildlife exposure. BPA causes reproductive system abnormalities and it 
has also several adverse effects on various systems such as skin, central nervous 
system and immune system. BPA is proposed to target spindle microtubules, 
microtubule-associated proteins, kinetochores and centromeres, centrioles and 
centrosomes, as well as DNA in the cell.  
The cytoskeleton is a network of filaments in cells that gives correct shape and 
proper structure to them. Three types of cytoskeletal filaments are common in 
eukaryotic cells, intermediate filaments, microtubules and microfilaments (actin 
filaments). Microtubule assembly and disassembly dynamics are crucial for both 
dividing and non-dividing cells in maintaining normal cellular function and 
morphologies. 
In this study, the effects of BPA on microtubules were investigated. Microtubule 
proteins were obtained from fresh bovine brain by two cycles of polymerization and 
depolymerization method. To analyze the effects of BPA on microtubule assembly 
and disassembly properties, sedimentation assays, fluorescence spectroscopy and 
electron microscopy techniques were used.  
The experimental results indicated that BPA inhibited microtubule polymerization 
and depolymerized taxol-stabilized microtubules. Electron micrographs showed that 
BPA caused changes in microtubule structures such as spiral, relaxed microtubules, 
consistent with depolymerization and disintegration. Results also suggested that BPA 
may show its effects on microtubules through microtubule-associated proteins. 
 
 1 
1. INTRODUCTION 
1.1. CYTOSKELETON 
The cytoskeleton is a network of filaments in cells that gives correct shape and 
proper structure to them. Many of the cells also have to be able to change their shape 
and move to other places. All cells have to rearrange their internal components as 
they grow, divide and adapt to changing circumstances. The cytoskeleton pulls the 
chromosomes apart at mitosis and splits the dividing cell into two. It drives and 
guides the intracellular traffic of organelles and materials inside the cell and also 
supports the fragile plasma membrane. The cytoskeleton  enables some cells, such as 
sperm, to swim and others, such as fibroblasts to crawl across surfaces and provides 
the machinery for the muscle cell contraction and extension of axons and dendrites in 
neurons [1].  
Three types of cytoskeletal filaments are common in eukaryotic cells, intermediate 
filaments, microtubules and actin filaments. Intermediate filaments are rope-like 
fibers and they have a diameter about 10 nm. These filaments provide mechanical 
strength and resistance to shear stresses. Microtubules are long, hollow cylindirical 
structures made of tubulin subunits. The diameter of a microtubule is 25 nm. 
Microtubules determine the position of organelles and direct intracellular transport. 
Actin filaments are also known as microfilaments. They are two-stranded helical 
polymers and have a diameter about 5-9 nm. They appear as flexible structures and 
are organized into linear bundles, two dimensional networks and three dimensional 
gels. Actin filaments are dispersed throughout the cell and mostly found in the 
cortex, just beneath the plasma membrane. Intermediate filaments are made of 
elongated and fibrous subunits, whereas actin filaments and microtubules are made 
of compact and globular subunits (actin subunits for actin filaments, tubulin subunits 
for microtubules) [1, 2, 3].  
A large number of accessory proteins link these filaments to each other and to other 
cell components. These are called “motor proteins” and they move membrane-bound 
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organelles and vesicles along the filaments or move the filaments themselves. These 
proteins use energy from ATP to walk or slide along a microtubule or a 
microfilament [1].  
The size of the cytoskeletal protein molecules is about a few nanometers. Large 
number of these small subunits assemble and build large structures. The subunits are 
small, so they can easily diffuse in cytoplasm, but the assembled filaments cannot. 
The cytoskeletal polymers are held together by hydrophobic interactions and weak 
noncovalent bonds, so assembly and disassembly of them occur rapidly. They are 
built of multiple protofilaments that are made of subunits joined end to end, and 
these protofilaments associate with each other laterally to form the hollow 
microtubule structure [1, 3].  
For a large filament to form, small subunits have to assemble into an initial nucleus, 
and then this is stabilized by many subunit-subunit contacts and can elongate rapidly 
by addition of more subunits. The process of the formation of the nucleus is called 
“nucleation”. If we initiate the polymerization in a test tube that contains pure protein 
subunits, an initial lag phase occurs and no filaments can be observed. During this 
lag phase, nuclei assemble and rapid filament elongation phase follows it where 
subunits add to the ends of the nucleated filaments. The system approaches to a 
steady state where the rate of addition of new subunits are balanced to the rate of 
dissociation of subunits. At this point the concentration of free subunits in the 
solution is called “critical concentration” (Cc) [1]. The more dynamic end of the 
filament where both growth and shrinkage are fast is called the plus end, and the 
other end is called the minus end [1, 2].   
1.1.1. ACTIN 
Actin is the most abundant intracellular protein in eukaryotic cells. It is encoded by a 
large, highly conserved gene family and is a moderate-sized protein that consists of 
375 residues [1, 4].  Actin filaments are composed of monomeric actin subunits that 
are single globular polypeptide chains [5]. A globular monomer is called “G-actin” 
and a filamentous polymer is called “F-actin” which is a linear chain of G-actin 
subunits [2]. Each actin subunit has a binding site for ATP, and actin subunits 
assemble head to tail to generate filaments with a structural polarity [5]. Also, each 
actin molecule contains a Mg+2 ion complexed with either ATP or ADP. When ATP 
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or ADP is bound to G-actin, it affects the conformation of the molecule. Without a 
bound nucleotide, G-actin denatures very quickly. The addition of ions (Mg+2, K+, or 
Na+) to a solution of G-actin induces the polymerization of G-actin subunits to F-
actin filaments. This is also reversible, when the ionic concentration is lowered F-
actin depolymerizes to G-actin [2, 6].  
The polymerization of actin filaments occurs in three phases (Figure 1.1). The first 
phase is called “nucleation phase” in which G-actin aggregates into short, unstable 
oligomers and then, these oligomers form a stable nucleus. In elongation phase, the 
filament elongates by the addition of actin monomers to both of its ends. The third 
phase is called “steady state” where there is no net change in the total mass of 
filaments. Once the steady state phase is reached, the equilibrium concentration in 
the pool of unassembled subunits is called the critical concentration (Cc). Above this 
value, G-actin polymerizes in a solution [1, 2, 4]. Accessory proteins are not required 
for polymerization in vivo. Also hydrolysis of ATP to ADP and Pi affect the 
polymerization kinetics but is not necessary for polymerization to occur [1]. On actin 
filaments, the ATP-binding site points towards the minus end [5]. Hence, all subunits 
have the same polarity. The rates of monomer addition to the ends of actin filaments 
differ because of the polarity. In the (+) end, elongation is five to ten times faster 
than the (–) end. This difference is caused by a difference in Cc values at the two 
ends [1, 2].  
 
 
 
 
The actin filament consists of two parallel protofilaments that twist around each 
other in a right-handed helix. In a living cell, actin filaments are cross-linked and 
bundled together by accessory proteins [5]. Actin filaments are arranged as bundles 
and networks in a cell, where organization of actin filaments are different depending 
Figure 1.1. The three phases of G-actin polymerization in vitro [1]. 
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on the type of the cell. In bundles the actin filaments are closely packed in parallel 
arrays, whereas in a network they crisscross and are loosely packed. In bundles and 
networks, the actin filaments are held together by actin cross-linking proteins [1, 2, 
6].  
The actin cytoskeleton powers the cell migration. It controls the shape of the cell 
because the actin cytoskeleton is so big that it can easily change cell morphology by 
assembling or disassembling itself. Also, cell shape is dependent on membrane-
microfilament binding proteins that connect the filaments to the membrane. The 
richest area of actin filaments in a cell lies in the cortex, just beneath the plasma 
membrane. Microvilli and filopodia are membrane projections that are supported by 
internal actin bundles [4, 7].  
Several actin-binding proteins are involved in the regulation of actin polymerization 
in cells [1, 6]. Thymosin 4 inhibits the actin assembly whereas profilin promotes the 
assembly. Some proteins control the lengths of actin filaments by severing them. 
They bind to actin filaments and break them into shorter fragments. Cofilin, gelsolin, 
severin are examples to these proteins [7, 8]. Also actin-capping proteins stabilize 
actin filaments. They bind to the ends of actin filaments and prevents the addition or 
loss of actin subunits from the ends where they bind. CapZ and tropomodulin are the 
examples of these proteins. Such capped actin filaments are needed in places where 
the organization of the cytoskeleton is not changing, as in muscle sarcomere or in the 
erythrocyte membrane. The severing and capping proteins are regulated by several 
signaling pathways [1].  
Actin polymerization and depolymerization create forces that produce several types 
of movement, such as the acrosome reaction of an echinoderm sperm cell, movement 
of intracellular pathogens and cell locomotion [1]. 
1.1.1.1. Myosin 
Myosin is an ATPase that moves along the actin filaments and hydrolyses ATP [1]. 
Myosin is a motor protein as it converts chemical energy into mechanical energy [9].   
Thirteen members of the myosin gene family have been identified. Myosin I and 
Myosin II are the most abundant and are present in nearly all eukaryotic cells. The 
specific activities of myosins differ, but they all function as motor proteins [1, 9].  
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All myosins are composed of one or two heavy chains and several light chains 
(Figure 1.2). The globular head domain contains actin- and ATP- binding sites, and it 
is responsible for generating force. The head domain is the most conserved region. 
Next to the head domain, - helical neck region lies and is associated with the light 
chains. It regulates the activity of the head domain. The tail domain contains the 
binding sites which determine the specific activities of a particular myosin in the cell 
[9, 10]. Myosin ATPase activity is actin-activated. In the absence of actin, myosin 
slowly converts ATP into ADP and Pi in solutions. When myosin is complexed with 
actin, the rate of myosin ATPase activity is four to five times faster than in the 
absence of actin [11].  
 
 
 
Myosin heads slide or walk along actin filaments. This movement is caused by the 
myosin head walking toward the (+) end of the filament [11].  
In muscle, actin and myosin associate in a complex called acto-myosin and they 
exploit to contract the muscle. According to the sliding-filament model of 
contraction in muscle, ATP-dependent interactions between  thick filaments 
(myosin) and thin filaments (actin) generate a force which causes thin filaments to 
slide past thick filaments. The force is generated by the myosin heads of thick 
filaments and the two filament systems overlap. Some conformational changes occur 
and these cause the myosin heads to walk along the actin filament. Contraction of an 
Figure 1.2. Structure of various myosin molecules [1]. 
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intact muscle results from the activity of myosin heads on a single thick filament, 
amplified by the thick filaments in a sarcomere and sarcomeres in a muscle fiber [12, 
13]. 
In nonmuscle cells, interactions of actin filaments with various myosins are 
important in such cellular functions as support, cytokinesis and transport. In cell 
adhesion, actin filaments and myosin II form contractile bundles as in sarcomeres. 
Also during cytokinesis, actin-myosin II bundle forms and pinches the dividing cell 
into two halves. Myosin I and myosin V power intracellular translocation of some 
vesicles along actin filaments [1, 14].       
1.1.2. MICROTUBULES 
Microtubules are responsible for various cell movements such as beating of cilia and 
flagella, the transport of membrane vesicles in the cytoplasm, the alignment and 
separation of chromosomes during meiosis and mitosis, and, in some protists, the 
capture of prey by spiny extensions of the surface membrane. They all result from 
the polymerization and depolymerization of microtubules or the actions of 
microtubule motor proteins. Microtubules also promote the extension of the neuronal 
growth cone, so they direct the migration of nerve-cell axons [1, 15]. 
1.1.2.1. Microtubule Structure 
Microtubules are formed from protein subunits of tubulin. Tubulin is a heterodimer 
formed from two related globular proteins called -tubulin and -tubulin [5]. Both of 
them have a molecular weight of 55 kD and highly conserved sequences that are 
found in all eukaryotes [16]. Another tubulin, -tubulin, is not a part of the 
microtubules, yet it nucleates the polymerization of - and - subunits to form 
microtubules [1]. - and -tubulin are bound together by noncovalent bonds. Each  
and  monomer has a binding site for GTP [5]. Each tubulin subunit has the ability to 
bind two molecules of GTP. GTP-binding site in -tubulin binds GTP irreversibly 
and does not hydrolyze it to GDP. The nucleotide on the -tubulin is exchangeable, 
because in -tubulin GTP is bound reversibly and is hydrolyzed to GDP [17]. The 
nonexchangeable GTP is located between the - and -tubulin monomers, whereas 
the exchangeable GTP lies at the surface of the subunit [1]. The hydrolysis of GTP to 
GDP at this site has an important effect on microtubule dynamics [5]. The guanine 
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nucleotide which is bound to -tubulin regulates the addition of tubulin subunits at 
the ends of the microtubule [3].  
Microtubule is a hollow cylindirical structure of 24 nm in diameter that is built from 
13 parallel protofilaments that are composed of - and - tubulin molecules [18]. 
Lateral and longitudinal interactions between the subunits are responsible for 
maintaining the tubular form. Longitudinal interactions link the subunits head to tail 
into a linear protofilament. The heterodimeric subunits repeat every 8 nm within each 
protofilament. By the lateral interactions, protofilaments associate side by side into a 
microtubule (Figure 1.3). A microtubule is a polar structure, and this polarity occurs 
because of the head-to-tail arrangement of the - and -tubulin dimers in a 
protofilament [1]. Subunits of each protofilaments in a microtubule point in the same 
direction.  subunits in a microtubule are exposed at the minus end while  subunits 
are exposed at the plus end [5].  
 
 
 
 
Microtubules form two types of structures: stable, long-lived microtubules and 
unstable, short-lived microtubules. Unstable microtubules assemble and disassemble 
quickly such as the cytosolic microtubule network in interphase cells during mitosis. 
In contrast to unstable microtubules, stable microtubules are usually found in non-
Figure 1.3. Assembly of microtubules. 1) Free tubulin dimers associate longitudinally to form 
protofilaments, 2) A sheet wraps around into a microtubule with 13 protofilaments, 3) 
Microtubule polymerization [1]. 
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replicating cells such as the axoneme in the flagellum of sperm, the marginal band of 
microtubules in most red blood cells and platelets, and the axons of neurons [1, 18].  
Microtubules assemble from a central organizing center by radiating in many 
interphase cells called microtubule-organizing center (MTOC) [19]. In animal cells, 
the MTOC is a centrosome. During mitosis, the centrosome duplicates and migrates 
to new positions. Duplicated centrosomes become the organization center for 
microtubules that form the bipolar mitotic apparatus. Then it will separate the 
chromosomes into the daughter cells during mitosis. In an interphase animal cell, the 
(-) ends of microtubules are proximal to the MTOC. In nerve cells, the (-) ends of 
axonal microtubules are oriented toward the base of the axon, but dendritic 
microtubules have mixed polarities [1, 20]. Some proteins are necessary for initiating 
the polymerization of microtubules. One of them is -tubulin. Introduction of 
antibodies against -tubulin into cells blocks microtubule polymerization process. 
That implicates -tubulin is necessary for nucleating assembly of tubulin subunits 
[1].  
1.1.2.2. Microtubule Dynamics 
A microtubule can undergo between growing and shortening phases, and this 
dynamic behavior lets the cell quickly assemble or disassemble microtubule 
structures. Microtubule assembly occurs by the polymerization of - and -tubulin 
dimers [15]. The polymerization process is temperature-dependent. If assembled 
microtubules are cooled down to 4 ºC, they depolymerize into dimeric subunits. And 
if tubulin dimers are warmed up to 37 ºC in the presence of GTP, they polymerize 
into microtubules [1]. Above the critical concentrations of tubulin dimers, 
microtubule polymerization initiates. Both assembly and disassembly occur faster at 
the (+) end than the (-) end [21]. Microtubule assembly occurs in three steps: tubulin 
dimers form protofilaments; protofilaments associate and form the wall of the 
microtubule; more subunits are added to the ends of protofilaments and the 
microtubule elongates [15].  
As mentioned, above the Cc, tubulin subunits polymerize into microtubules, whereas 
below the Cc, microtubule depolymerization into tubulin subunits occurs. Under in 
vitro conditions, tubulin subunits add to one end and dissociate from the opposite end 
of the microtubule and this process is called “treadmilling”. In all cases, the rate of 
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microtubule lengthening is much slower than the rate of shortening. This property of 
microtubules is termed “dynamic instability” [1]. 
1.1.2.3. Microtubule-Associated Proteins (MAPs) 
Microtubule-associated proteins (MAPs) have the ability to bind microtubules. They 
cross-link microtubules to one another and other structures in the cytosol [22]. 
Assembly MAPs are organized into two domains: a basic microtubule-binding 
domain and an acidic projection domain. The projection domain appears as a 
filamentous arm in the electron microscope and it extends from the wall of the 
microtubule. It can bind to membranes, intermediate filaments, other microtubules 
and its length controls how far apart microtubules are spaced [1, 23]. 
Assembly MAPs are grouped into two types by the sequence analysis. Type I MAPs 
are MAP1A and MAP1B. These are large and filamentous molecules and are found 
in axons and dendrites of neurons and also in non-neuronal cells [1].  
Type II MAPs are MAP2, MAP4, and Tau (Figure 1.4). MAP2 is found only in 
dendrites. It forms fibrous cross-bridges between microtubules and also between 
microtubules and intermediate filaments. MAP4 is the most ubiquitous one and is 
found in neuronal and non-neuronal cells. MAP4 is thought to regulate microtubule 
stability during mitosis. Tau is found in both axons and dendrites and it is present in 
four or five forms derived from alternative splicing of a Tau mRNA. It cross-links 
microtubules into thick bundles and it may contribute to the stability of axonal 
microtubules [1, 22]. 
 
 
 
Some MAPs like MAP4 and Tau stabilize microtubules but others do not. MAPs-
coated microtubules are unable to disassemble. Hence, tubulin subunits can not 
dissociate when bound with MAPs. Some phosphorylating enzymes such as MAP 
Figure 1.4. A) MAP2 binds along the microtubule lattice at one end and extends a long projecting 
arm with a second microtubule-binding domain at the other end. B) Tau binds to the microtubule 
lattice at both its N- and C-termini, with a short projecting loop [1]. 
A) B) 
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kinase (phosphorylating MAPs) and cdc2 kinase (phosphorylating MAP4) 
phosphorylate the projection domains of MAPs reversibly. Phosphorylated MAPs 
can not bind to microtubules and microtubule disassembly occurs [1, 23].  
1.1.2.4. Intracellular Transport 
Proteins, organelles and membrane-coated vesicles are transported to the defined 
addresses in the cytosol. Microtubules function as tracks in the intracellular transport 
of all these, and that movement is propelled by microtubule motor proteins [24] 
(Figure 1.5). 
 
 
“ 
 
Neuronal axons do not contain ribosomes, hence the protein synthesis only occurs in 
the cell body and dendrites of the neuron. Therefore, proteins synthesized in the cell 
body must be  transported down to the axon. Axonal transport occurs on 
microtubules. In axons, microtubules are oriented with their (+) ends toward the 
terminal that is critical for axonal transport [25]. 
Melanophores, specialized pigment cells, are found in the skin of many amphibians 
and fish. Transport of the pigment granules throughout the cell or toward the center 
of the cell results in the change of the color of the skin. During these movements, 
microtubules serve as tracks along that the pigment granules can move in either 
direction [1, 24]. 
Figure 1.5. A general model for kinesin- and dynein-mediated transport in a typical cell. 
The array of microtubules, with their (+) ends pointing toward the cell periphery, radiates 
from a MTOC in the Golgi region [1]. 
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1.1.2.5. Kinesin and Dynein, Microtubule Motor Proteins 
Kinesin 
Kinesin is a dimer of two heavy chains and each is complexed with a light chain. It 
has a total molecular weight of 380,000. Kinesin has three domains, a pair of large 
globular head domains that is connected to a pair of small globular tail domains by a 
central stalk. Tail domains contain light chains. Each domain has a particular 
function. The head domain binds microtubules and ATP, and is responsible for the 
motor activity of kinesin. The tail domain binds membrane-bound vesicles that are 
referred to as kinesin’s cargoes [1, 26]. 
Kinesin is a (+) end-directed microtubule motor protein. It walks towards the (+) end 
of the microtubule. Kinesin is responsible for anterograde and other (+) end-directed 
movements, such as the transport of secretory vesicles to the plasma membrane and 
the radial movements of endoplasmic reticulum membranes and pigment granules 
[24, 27]. 
Kinesin belongs to a family which has more than 12 different members. They all 
contain the kinesin motor domain, but their tail domains are different and they have 
different several other properties [1]. In most kinesins, the motor domain is at the N-
terminus (N-type), but in some, the motor domain is central (M-type) or at the C-
terminus (C-type). N- and M-type kinesins are (+) end-directed motors, whereas C-
type kinesins are (-) end-directed motors. Also some kinesins are monomeric, 
whereas most are dimeric. These two types of kinesins differ in quaternary structure 
[28]. 
According to the cargo they transport, kinesins can be divided into two functional 
groups, cytosolic and spindle kinesins. Cytosolic kinesins are responsible for the 
transport of  vesicles and organelles. Axonal kinesin is an example to them. It 
transports lysosomes and other membranous organelles. Some cytosolic kinesins are 
responsible for the transport of one specific cargo. For example, KIF1B transports 
mitochondria and KIF1A transports synaptic vesicles to the nerve terminal. Spindle 
kinesins function in spindle assembly and chromosome segregation during cell 
division. For example, the kinetochore-associated protein CENP-E, the spindle pole 
protein BimC, and a (-) end-directed motor called ncd [1, 25]. 
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Dynein 
Dynein is responsible for movement toward the (-) end of microtubules. Dyneins are 
large, multimeric proteins and their molecular weight exceeds 1,000,000 D. They 
have two or three heavy chains associated with intermediate and light chains [1]. 
Dyneins are divided into two groups according to their functions: cytosolic dyneins 
are involved in the movement of vesicles and chromosomes whereas axonemal 
dyneins are responsible for the beating of cilia and flagella. Cytosolic dynein has two 
head domains that are formed by two identical or nearly identical heavy chains [27].  
Unlike kinesin, dynein can not mediate transport by itself. A large complex of 
microtubule-binding proteins are required for dynein-related motility. These proteins 
link vesicles and chromosomes to microtubules but do not exert force to cause 
movement. The best known complex is dynactin. It includes a protein called Glued, 
the actin-capping protein Arp1, and dynamatin [29]. In vitro experiments show that 
dynactin enhances dynein-dependent motility by the interaction with microtubules 
and vesicles. Glued has a microtubule-binding site at its N-terminal region. In this 
complex, the light chains of dynein interact with the dynamatin. As a model, 
dynactin tethers a vesicle to a microtubule, while dynein generates the force and 
polarity for movement [1, 29].   
1.1.2.6. Microtubule Dynamics during Mitosis 
During mitosis newly replicated chromosomes are separated into two daughter cells. 
The cell assembles and then disassembles a specialized microtubule structure called 
mitotic apparatus. The mitotic apparatus attaches and capture chromosomes, align 
and then separate them, so the genetic material is partitioned to each daughter cell 
[30]. This portion of the cell cycle is divided into four stages: prophase, metaphase, 
anaphase, and telophase. Mistakes in mitosis can lead to missing or extra 
chromosomes that result in developmental abnormalities during embryogenesis and 
pathologies after birth. Therefore microtubule motor proteins and microtubule 
dynamics have both crucial roles during mitosis [1, 30]. 
The mitotic apparatus has a changing structure during mitosis. Three distinct sets of 
microtubules form the mitotic spindle. Two centrosomes at the opposite poles 
organize the microtubules whose (-) ends all point toward the centrosome. First, the 
astral microtubules form the aster, they radiate outward from the centrosome to the 
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cell cortex. They help position the mitotoic apparatus and also have a role in 
determining the cleavage plane during cytokinesis. Second, kinetochore microtubules 
attach to chromosomes at particular sites on chromosomes called kinetochores. 
Third, polar microtubules do not interact with chromosomes, but they interdigitate 
with polar microtubules from the opposite pole. The mitotic spindle is composed of 
kinetochore and polar microtubules (Figure 1.6) [1, 30]. 
 
 
First change in microtubule stability occurs at prophase during mitosis. Long 
interphase microtubules disappear and are replaced by a spindle and astral 
microtubules. The average lifetime of a microtubule decreases from 10 minutes in 
interphase cells to 30 seconds in the mitotic spindle. This high tubulin turnover 
enables microtubules to assemble and disassemble more quickly during mitosis [31]. 
Attachment of spindle microtubules to the poles and then capture of chromosomes by 
kinetochore microtubules are required for the assembly of the spindle. The two 
centrioles in the centrosome, the MTOC in most animal cells, are replicated during 
interphase. With the beginning of mitosis, they migrate to the two poles and organize 
the astral microtubules. Interactions between asters and the cell cortex and between 
opposing spindle microtubules separate and align the centrosomes during prophase. 
This establishes the bipolar orientation of the spindle. At metaphase spindle 
microtubules capture the kinetochores of chromosomes and center the chromosomes. 
Microtubule polymerization and depolymerization and microtubule motor proteins 
together holds chromosomes at the metaphase plate and translocates chromosomes to 
the opposite poles at anaphase. And during cytokinesis, cleavage occurs between the 
asters [1, 30, 32]. 
Figure 1.6. Three sets of microtubules in the mitotic apparatus [1]. 
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1.1.2.7. Some Drugs That Affect Microtubule Dynamics  
Several drugs inhibit mitosis by affecting microtubule assembly and disassembly. 
Colchicine, taxol, and vinblastine are known to bind - and -tubulins or 
microtubules. Cochicine and colcemid have been used as mitotic inhibitors. With 
high concentrations of colcemid, cytosolic microtubules depolymerize and they leave 
MTOC, whereas at low concentrations, the microtubules remain and the cell 
becomes blocked at metaphase. When the cells are washed with a colcemid-free 
solution, colcemid diffuses from the cell and mitosis goes normally. If colchicine-
bearing tubulins are added to the ends of a microtubule, addition or loss of other 
tubulin subunits are prevented. Taxol and vinblastine bind to microtubules and 
stabilize them. They inhibit microtubule dynamics, lengthening and shortening of 
microtubules.  
Drugs which disturb the assembly and disassembly of microtubules have been widely 
used to treat various diseases. More than 2500 years ago, heart diseases had been 
treated with colchicine in the ancient Egypt. And now colchicine is used to treat gout 
and some other disease that affect the joints and skin. Taxol and vinblastine are 
effective anticancer agents, because blockage of spindle formation preferentially 
inhibits rapidly dividing cells like cancer cells. For example, taxol is used in the 
treatment of ovarian cancer cells. Taxol blocks mitosis in these cells but does not 
affect other functions performed by microtubules [1, 33].     
1.2. XENOESTROGENS 
Xenoestrogens are chemicals with diverse structures that mimic estrogen. These are 
pesticides and industrial by-products with little or no structural homology to estradiol 
that are common in the environment and act as agonists or antagonists of estrogens 
[34]. Because they mimic endogenous hormones or interfere with endocrine 
processes, they are called endocrine disrupters. Xenoestrogens are hydrophobic, and 
enter the body easily by diffusion through biological membranes, and accumulate in 
hydrophobic compartments of the cell, where they can disturb normal cellular 
functions. The proposed targets in cells include spindle microtubules, MT-associated 
proteins, kinetochores and centromeres, centrioles and centrosomes, as well as DNA. 
Two types of genetic changes can be thought; numerical chromosome changes 
(aneuploidy) with no apparent DNA damage, and structural chromosome aberrations 
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induced by catechol metabolites presumably through DNA damage. They may 
interfere with spindle apparatus during mitosis resulting abnormal segregation of 
chromosomes or inhibit MT assembly [35].         
1.2.1. BISPHENOL A 
Investigators from Stanford University identified an estrogen-binding protein in yeast 
and then investigated whether yeast have an endogenous ligand. After first reporting 
that yeast produce estradiol, they found that the estrogenic activity did not come 
from the yeast, but from culture media that were prepared with water autoclaved in 
polycarbonate flasks. With binding to estrogen receptor used as a bioassay, the 
estrogenic compound was purified and identified as bisphenol A (BPA) [34]. 
Bisphenol A is a common name for 2,2-(4,4-diydroxydiphenyl) propane [36]. 
The estrogenicity of bisphenols was reported for the first time in 1936 by Dodds and 
Lawson, who looked for synthetic estrogens devoid of the phenantrenic nucleus. 
Bisphenols were subsequently discarded for pharmaceutical purposes. In 1944, Reid 
and Wilson again studied the relationship of the structure of some bisphenols to 
estrogenic activity in vivo compared with stilbene derivatives. The early reported 
estrogenicity of bisphenols was not considered a toxicological problem, and new 
bisphenols were synthesized for use in many industrial applications. Concern about 
the estrogenicity of bisphenols in plastics and the consequences of human exposure 
to them was raised by Krishnan, who suggested that BPA was responsible for the 
estrogenicity of water sterilised in polycarbonate flasks. Rivas et al. later 
demonstrated the leaching of various bisphenols (BPA and methyl-BPA) from food 
cans and dental sealants (BPA and BPA dimethacrylate). Hashimoto and Nakamura 
showed the estrogenicity of a range of bisphenols used as dental materials [37]. 
It is thought that the estrogenic activity of these chemicals cause reproductive 
disorders and various types of cancer. The effects of these estrogens are thought to 
target the cytoskeletal structures such as microtubules. To show the effects of 
xenoestrogens on cytoskeletal proteins, we have chosen BPA. 
1.2.1.1. Structure 
Bisphenols is a broad term that includes many substances.They have two phenolic 
rings joined together through a bridging carbon as a common chemical structure 
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(Figure 1.7) [35, 37]. BPA is produced by an acid-catalyzed reaction of phenol and 
acetone and is composed of two unsaturated phenol rings [34]. 
 
 
Table 1 shows the physical and chemical properties of BPA. 
  
     
Parameter Value 
CAS No. 80-05-7 
Molecular Weight 228 g/mol 
Formula C15H16O2 
Specific Gravity 1.060 g/cm3 
1.195 g/cm3 
Boiling Point 220 C (at 4 mmHg) 
398 C (at 760 mmHg) 
Melting Point 150-155 C 
157 C 
PKa 9.59, 10.2 
11.30 
Water Solubility 120,000 g/L 
300,000 g/L 
Vapor Pressure 4.0E-8 mmHg 
3.96E-7 mmHg 
8.70E-10 mmHg 
3.96E-9 mmHg 
                    
1.2.1.2. Usage 
Bisphenols, in particular bisphenol A (BPA), are monomers of various plastics 
including polycarbonates, epoxy and other resins which are used in numerous 
consumer products [35]. Most BPA is used in the manufacture of polycarbonate 
(60%) and epoxy resins (30%), with the remaining 10% being used for the 
production of polyester resins. Polycarbonate, composed of BPA monomers, has 
many desirable commercial qualities such as transparency, moldability and high 
impact strength [34]. Polycarbonates are used in a variety of consumer products, 
Figure 1.7. Chemical structure of bisphenol A [35]. 
Table 1.1. Physical and Chemical Properties of Bisphenol A [36]. 
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including a number of that come into contact with food, such as returnable beverage 
containers, infant feeding bottles, plastic dinnerware, and plastic storage containers. 
In addition, they are used in non-food consumer goods, such as eyeglass lenses, 
electrical equipment, household appliances, and sport safety equipment [38]. The 
carbonate linkages are rather stable, but can be hydrolyzed at high temperature and 
neutral pH, resulting in release of BPA. Epoxy resins are common lacquer-coatings 
of cans in the food industry and are also used for composites and sealants in dentistry 
[35]. Epoxy resins containing BPA diglycidylether (BADGE) have superior adhesive 
properties. When reacted with a hardener, they become cross-linked and can be used 
in coating or bonding applications. BPA diglycidyl methacrylate (bis-GMA) is a 
constituent of dental sealants used to replace tooth structures. Their polymerization 
(curing) reaction is photo-initiated by UV or visible light. Incompletely polymerized 
resins may contain 5-10% of free BPA [34]. BPA is also used in lesser amounts in 
various applications, for example, as an intermediary in thermal paper production 
and as an antioxidant and inhibitor of end polymerization in the manufacture of 
poly(vinyl chloride) plastics [38]. 
1.2.1.3. Exposure – Prevalence 
Due to their use in food packing materials and many household products, bisphenols 
have the potential for widespread occupational and consumer exposure [35]. Because 
BPA is used in the manufacture of a variety of high-volume consumer products, 
there are a number of possible routes of exposure for members of the general 
population. These can be (1) direct and indirect environmental exposure due to the 
release of BPA during its production, use, and disposal; (2) exposure through leaching 
into food; and (3) contact with or inhalation of non-food-contact consumer products. 
BPA has been in use commercially for over 50 years, and workers producing this 
compound and its products (eg, epoxy resins) have been exposed to time-weighted 
average air levels to about 10 mg/m3 over decades. From this experience, it has been 
found that high exposures to BPA are irritating to the eye and respiratory tract, and 
may cause skin lesions and photosensitization of the skin. No studies reporting 
systemic effects were identified, and no epidemiologic studies of workers who have 
been exposed occupationally were found [38].  
For the last 40 years, substantial evidence has surfaced on the hormone-like effects 
of environmental chemicals such as pesticides and industrial chemicals in wildlife 
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and humans. The endocrine and reproductive effects of these chemicals are believed 
to be due to their ability to: (1) mimic the effect of endogenous hormones, (2) 
antagonize the effect of endogenous hormones, (3) disrupt the synthesis and 
metabolism of endogenous hormones, and (4) disrupt the synthesis and metabolism of 
hormone receptors. The discovery of hormone-like activity of these chemicals 
occured long after they were released into the environment [39]. Bisphenol A (BPA) 
is a particularly important environmental estrogen. Not only is it widespread in the 
environment, but it is commonly ingested by humans, being released by 
polycarbonate plastics, the lining of food cans, and dental sealants. BPA has a weak 
estrogenic activity in vitro and in vivo, but recent evidence indicates that this 
substance is able to interact with the estrogen receptor- (ERa) in a unique manner, 
somewhat different from estradiol [40]. BPA has about 1/10000 the biological 
activity of estradiol [41].  
These estrogenic compounds also alter cell cycle kinetics, induce DNA damages, and 
produce telomeric associations and chromosomal aberrations. Whether weak or 
strong, the estrogenic response of a chemical, if not overcome, will add extra 
estrogenic burden to the system, and particularly those endocrine disrupting 
environmental and industrial estrogen-like chemicals capable of producing genomic 
instability will induce additional burden of genomic instability. Though, 
estrogenically some of these compounds may be weak, they may have different 
activities in generation of genomic instability [42].  
Biologic effects of BPA, which has been proven to interact with estrogen receptors, 
include enhancement of prolactin gene expression in pituitary cells, promotion of 
hyperplasia and differentiation in the female reproductive tract epithelium of rats, 
and acceleration of growth and puberty in female mice. In addition, estrogenic 
alkylphenols including BPA have been shown to induce apoptosis in several types of 
cells [43]. 
When given to pregnant mice, BPA crosses the placenta and reaches fetal organs. 
Cytochrome P450 works to reduce estrogens, and glucuronosyl-transferase degrades 
BPA. Since the fetus does not express this enzyme and BPA crosses the placenta, the 
fetus may lack protection from the effects of this exogenous estrogen [44]. 
Additionally, it binds to -fetoprotein with affinity relative to estradiol, this results in 
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its enhanced bioavailability during neonatal development [45]. Also when given to 
mother during lactation, BPA is transferred to neonatal infants via milk [46]. 
Following the observation that BPA leached from autoclavable polycarbonate 
laboratory flasks, it was recently reported that BPA is released from the epoxy resin 
lining of food cans (4-23 g per can; 7-380 g/kg) and from restorative materials 
used in dentistry (90-913 g in saliva collected in a 1-hour period following 
application of dental sealant) [35, 45]. Olea et al. have reported the presence of BPA 
in foods preserved by canning in polycarbonate-lined tin cans. It was found that BPA 
leaches from the treated teeth into saliva; up to 950 g of BPA were retrieved from 
saliva collected during the first hour after polymerization [39]. 
There is increasing concern about the potential negative impact on public health of a 
class of environmental chemicals with estrogenic activity: the potential effects of 
these environmental estrogens include breast cancer, reduced sperms counts, and a 
variety of reproductive abnormalities [40]. Exposure to BPA with skin contact results 
in skin lesions and occupationally may result in photosensitisation in humans [47]. 
Additionally, results of some studies have shown that estrogenic chemicals including 
BPA and DES can act at very low doses in the range of human and wildlife 
environmental exposures [44]. 
BPA has been known to cause extensive damage to various organs in a human who 
absorbed it through the skin. It is also known to cause adverse reproductive effects in 
rats and mice [48].  
BPA is able to affect in mice the development of reproductive organs and their 
function in the male offspring of mothers fed with this chemical during pregnancy 
[40]. Animal experiments indicated effects such as uterotrophic effects, decreasing 
sperm production, stimulation of prolactin release, promotion of cell proliferation in 
a breast cancer cell line and influence on preimplantation development [49]. 
Female rats treated with BPA by administration via drinking water during gestation 
produced male offspring with smaller testes. Low-dose exposure in mice has also 
been reported to result in increased prostate weight and reduced daily sperm 
production per gram testis [50].  
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Exposure of BPA within the range of human exposure (2-20 g/kg) in pregnant mice 
during last gestation days resulted in small increases in prostate (30-36%) and 
preputial gland weights and small decreases in daily sperm production (20%) and 
epididymal weights (12%) of adult male offspring that are 6 months old [41]. 
Exposure of pregnant mice to 20 g/kg BPA during last gestational days induced 
both vaginal opening and first vaginal estrus at a significantly earlier age in female 
offspring [45]. 
Exposure of the developing mouse fetus to BPA (25-250 g/kg) showed that the 
virgin mice at puberty exhibit mammary glands that resemble those of pregnant 
mice. This is reflected by a significant increase in the percentage of ducts, terminal 
end buds, terminal ducts and alveolar buds [45]. 
BPA administration to female rats (100-1000 mg/kg) by gavage during the entire 
period of pregnancy produced pregnancy failure, pre- and postimplantation loss, fetal 
developmental delay and severe maternal toxicity [51]. To investigate the adverse 
effects of BPA on initiation and maintenance of pregnancy and embryofetal 
development, rats were administered to BPA during the entire period of  pregnancy. 
The results indicated pregnancy failure, increased pre- and postimplantation loss, 
decreased fetal body weight and retarded fetal ossification at a maternally toxic dose. 
However, BPA did not induce embryofetal dysmorphogenesis [51].   
It was shown that BPA induced cell proliferation and progesteron receptor synthesis 
in estrogen-dependent MCF-7 human breast cancer cells [52]. 
Iida et al. demonstrated that exposure of cultured Sertoli cells to BPA decreased the 
cell viability in a dose- and a time-dependent manner and that exposure to BPA 
brought about morphologic changes of the cells, such as membrane blebs, cell 
rounding, cytoskeletal collapse, and chromatin condensation or fragmentation, all of 
which conform to the morphologic criteria for apoptosis. Apoptosis-inducing cell 
death was observed in cells exposed to 150-200 M BPA, while BPA at <100 M 
had only slight cytotoxic effects on the cells [43].  
Oral administration of BPA in mice and rats resulted in changes in size and 
nucleation of hepatocytes of liver in a 90-day study [47]. 
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Oka et al. demonstrated that BPA induced marked malformations and specific 
apoptosis of central nervous system cells during early development of Xenopus laevis 
embryos, and that these BPA effects appeared to be due to non-estrogenic activities 
on developmental processes [53]. 
Suzuki et al. reported that, in goldfish at 8 days after treatment, BPA induced 
vitellogenin synthesis but decreased the plasma calcium level and inhibited secretion 
of the calcium-regulating hormone, calcitonin [54]. 
Katoh et al. concluded that BPA possessed a suppressing action on GH synthesis and 
release, and this suppressing action is probably related to impairment of cellular 
signal transduction systems in ovine anterior pituitary cells [55].  
It was shown that BPA affected the transcriptional activities of thyroid hormone 
receptors in transfected human embryonic kidney cells [47]. 
During central nervous system (CNS) development, programmed neuronal cell death 
is an essential procedure in the early stages in which caspase-3 plays an important 
role. Because 17-estradiol is known to have a protective effect against neuronal cell 
death against models of neurodegenerative disorders such as Alzheimer’s disease, 
Negishi et al. hypothesized that BPA might influenced neuronal cell death and 
caspase-3 activation in cultured neurons. They showed the inhibitory effect of BPA 
on caspase-3 activity in CNS neurons and neuronal cell death in cultured neurons 
[56].   
It is probable that endocrine disrupters also affect the differentiation and 
development of brains because the volume and/or the number of neurons in some 
hypothalamic nuclei are determined by the organizational action of estrogen, 
producing sex differences in the structure and function of the hypothalamic and 
extrahypothalamic nuclei [57]. 
Steinmetz et al. indicated that BPA induced molecular and morphologic alterations 
in the uterus and vagina of adult rats by inducing DNA synthesis and c-fos gene 
expression [44].  
Neonatal treatment of rats with BPA and some other endocrine disrupting chemicals 
(EDCs) resulted in motor hyperactivity. It has been suggested that these EDCs might 
inhibit the development of dopamine neurons in brain. According to data, neonatal 
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treatment with EDCs provides an animal model of hyperkinetic disorder that includes 
the variation seen in a clinical setting [58].  
Various aspects of non-social behavior are affected by perinatal exposure to BPA. 
This confirms the hypothesis that exposure to an environmental estrogen in the 
critical period of sexual differentiation can permanently influence the neural systems 
involved in the organization of behavior [40]. The effects of BPA on the sexual 
differentiation of the norepinephrine system and related behaviors were examined in 
rats. Pregnant rats were administered with BPA at a dosage that is less than the 
tolerable daily intake level during both pregnancy and lactation. The findings 
suggested that higher brain functions such as learning and emotional control are 
under the influence of chemical impacts including BPA [59].  
Pregnant rats were exposed to BPA (40-400 g/kg) from day 14 of gestation through 
postnatal day 6. Female offspring exhibited depressed motor activity and male 
offspring exhibited reduced anxiety-like behaviors [45]. Also, effects of BPA on 
maternal behavior were studied by giving low doses of BPA to adult female rats 
during pregnancy and lactation. BPA modified the behavior of mothers. Specific 
components of maternal behavior were reduced both active and passive, irrespective 
of the sex of pups and the period of observation [49].   
Because estrogen and DES have been reported to induce immunosuppression and 
reduce host resistance to infectious disease, Konishi et al. examined the effects of 
BPA on immune system. BPA treated mice were injected with E.coli K-12. BPA 
pretreatment caused a decrease of T and B cell populations, macrophages and 
lymphocytes in the spleen of treated mice. When compared with non-treated mice, 
the eliminating activity in treated mice was diminished. Their results suggested that 
BPA possessed immunotoxicity and reduced the non-specific host defense as an 
acute toxicity [60]. Byun et al. also investigated the toxicity of BPA on immune 
responses. They proposed that BPA induced a generalized suppression of 
macrophage activation in vitro and nitric oxide (NO) and tumour necrosis factor 
(TNF)- release are suppressed as well [61].  
Takahashi et al. tested the mutagenicity of BPA using human RSa cells. The cells 
were treated with very low doses of BPA. They detected increased base substitution 
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mutations at K-ras codon 12 using PCR and dot-blot hybridization. This is the first 
study of base substitution mutations induced by BPA in human cells [62]. 
No epidemiological data relevant to the carcinogenicity of BPA are available. BPA 
was tested for carcinogenicity in 2-year feeding studies in rats and mice. In male and 
female rats, a small, not statistically significant increase in leukaemias was observed 
compared to the control group. Slight increases in the frequency of mammary gland 
fibroadenomas in male rats was thought to be a chance finding. In female rats, 
fibroadenoma incidence was not significantly increased. Also, an increased incidence 
in interstitial cell tumors (benign leydig cell tumors) in male rats was significantly 
higher both in the low-dose and the high-dose groups compared to the control group 
[63, 47]. In rats, body weight gain and feed consumption were reduced in treated 
groups compared to control groups. Other treatment-related findings were not 
observed [63].  
Kabuto et al. suggested that pathological conditions caused by BPA may be related 
to the generation of reactive oxygen species and free radicals that are generated by 
BPA metabolism or estrogen-receptor-mediated systems. They also thought that 
BPA may affected reproductive and sexual characteristics by disturbing redox 
control systems. Their results showed that the injection of BPA induced 
overproduction of hydrogen peroxide in the mouse organs which is converted to 
hydroxy radical [64]. After that they investigated the modifications in endogenous 
antioxidant capacity and oxidative damage in the brain, liver, kidney and testis. Mice 
were exposed to BPA during embryonic, fetal life and lactation via their mothers. As 
a result, reactive oxygen species were induced in organs. Tissue oxidative stress and 
peroxidation were induced, ultimately leading to underdevelopment of the brain, 
kidney and testis [46]. 
In light of reports suggesting that low doses of BPA cause estrogenic effects in 
laboratory animals, concerns were raised about the safety of these consumer 
products, particularly plastic bottles used for feeding milk to babies. To evaluate the 
risk, if any, from BPA, investigations were undertaken to more precisely determine 
human exposure levels and more carefully study the validity of the low-dose effects 
reported. On the basis of the most realistic studies of BPA levels in food and drink, 
as well as in human urine, it has been estimated that human exposures, including 
those of children, are very low and range from about .001 to .1 mcg/kg body weight 
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(bw)/day. Human doses of BPA from migration of the compound into food and drink 
are orders of magnitude lower than acceptable daily intakes. Thus, it is very unlikely 
that humans, including infants and young children, are at risk from the presence of 
BPA in consumer products [38]. 
1.3. EFFECTS OF BPA ON MICROTUBULES 
Several estrogens of diverse classes were studied for their ability to interfere with the 
assembly and disassembly of microtubules under cell-free conditions. Inhibition of 
microtubules in intact cells may lead to some changes such as the induction of 
micronuclei and aneuploidy. Thereby, they contribute to estrogen-mediated 
carcinogenesis. Natural estrogens, e.g., 17-estradiol (E2), and synthetic estrogens, 
e.g., diethylstilbestrol (DES) are known to be associated with human neoplasia. In 
experimental animals E2 and DES as well as several of their analogs induce tumors 
in various tissues. In short-term assays, carcinogenic estrogens fail to induce gene 
mutations and DNA damage but lead to numerical and structural chromosomal 
aberrations. Several laboratories have reported that DES has colchicinelike effects, it 
causes the inhibition of microtubule polymerization under cell-free conditions as 
well as disruption of the mitotic spindle and the cytoplasmic microtubule complex in 
mammalian cells. The plastic estrogen bisphenol A (BPA) proved to be a powerful 
inhibitor that exhibits about half the activity of DES [65].  
BPA disrupts the cytoplasmic microtubule complex and mitotic spindle (reversible) 
and can induce metaphase arrest and micronuclei in cultured Chinese hamster V79 
cells. After treatment with BPA (200 M), the mitotic spindle of all metaphase cells 
was no longer visible and diffuse tubulin stains were surrounded by chromosomes in 
an irregular arrangement. All these effects suggest that BPA and some of its analogs 
are potential aneuploidogens and microtubules are the main targets of DES and many 
other aneuploidogens [35, 66]. 
DES, E2 and BPA caused mitotic arrest and aberrant spindles, such as tripolar and 
multipolar spindles, in a concentration-dependent manner. Ochi et al. suggested that 
multiple microtubule nucleating sites were induced by the estrogens and BPA during 
the transition from interphase to the mitotic phase. DES, E2 and BPA induced 
multipolar division in a concentration-dependent process that is associated with the 
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induction of aneuploidy. The multipolar spindles are related to cell death, cell 
differentiation and malignant transformation via induction of an unequal 
chromosome distribution (aneuploidy). Also centrosome damage could be 
responsible for the induction of aberrant mitotic spindles. Centrosomes are composed 
of two centrioles that are surrounded by pericentriolar materials. Microtubules are 
nucleated on pericentriolar materials that are called microtubule-organizing centers 
(MTOCs). The MTOCs nucleate the microtubule assembly and form the microtubule 
polarity. So, centrosomal injury by estrogens could be involved in the induction of 
aberrant spindles. Ochi et al. demonstrated induction of multipolar spindles and 
alterations in centrosome organization as a mechanism for the induction of aberrant 
mitotic spindles by estrogens and BPA. Also it was demonstrated that induction of 
multipolar division by estrogens and BPA was associated with the induction of 
aneuploidy. The mitotic index of cells treated with BPA increased over the control 
levels [48, 67]. 
DES and its derivatives have been reported to inhibit microtubule assembly both in 
culture cells and in cultured cells. Also estradiol depolymerized the intracellular 
microtubule network in Chinese hamster V79 cells. It has been suggested that the 
induction of microtubule disruption is not related to binding of estrogens to their 
receptors. Nakagomi et al. suggested that some endocrine disrupting chemicals 
including DES, E2 and BPA have disruptive effects on the microtubule network in 
Chinese hamster V79 cells [66]. 
Hunt et al. encountered with a sudden, spontaneous increase in meiotic disturbances, 
including aneuploidy, in studies of oocytes from control female mice in their 
laboratory coincided with the accidental exposure of the animals to BPA. They 
identified that the damaged caging material and water bottles were the source of the 
exposure. In further experiments, they administered daily oral doses of BPA to 
directly test the hypothesis that low levels of BPA disrupt female meiosis. Finally, 
they demonstrated that the meiotic effects by BPA were dose dependent and could be 
induced by environmentally relevant doses of BPA. The exposure was correlated 
with highly significant increases in meiotic chromosome abnormalities, including 
nondisjunction and congression failure which is a specific meiotic phenotype at 
metaphase, therefore they implicated BPA as a potent disrupter of meiosis [68]. 
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To investigate the aneuploidogenic potential of BPA, Lehmann et al. studied with 
cultured human AG01522C fibroblasts. In contrast to DES and 17-estradiol, BPA 
did not induce micronuclei at any concentration. It inhibited the proliferation of the 
cultured cells in G2 phase and probably in G1 phase. Fluorescence microscopy of the 
BPA treated cells showed structural abnormalities of the cytoplasmic microtubule 
complex (CMTC) in a dose-dependent manner. The mitotic index did not increase 
and decrease in cell growth was dose-dependent. The mechanisms of growth 
inhibition and the interference with microtubules elicited by BPA in AG01522C cells 
are still unknown. Two mechanisms could be mentioned: (1) BPA may directly affect 
microtubules and impair their ability to depolymerize and repolymerize; and (2) BPA 
may primarily arrest the cell cycle and thereby affect microtubule dynamics [67].  
Our project proposes to show the direct effects of BPA on microtubule proteins in 
vitro by sedimentation assay, fluorescence spectrometry and electron microscopy 
techniques. By using these techniques, we can analyze the possible changes in the 
assembly and disassembly properties of microtubules. 
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2. MATERIALS AND METHODS 
2.1. Materials 
2.1.1. Buffers for Tubulin Purification 
2.1.1.1. 5X PM Buffer 
500 mM Pipes-NaOH (Roche), 10 mM EGTA (Sigma) and 5 mM MgSO4.7H2O 
(Riedel-de Haen) were dissolved in deionized water up to 1 lt. and pH was adjusted 
to 6.9 with NaOH. It was stored at 4C. 
2.1.1.2. 1X PM Buffer 
5X PM buffer was diluted with deionized water five times and pH was adjusted to 
6.9. It was stored at 4C. 
2.1.1.3. PM-4M Buffer 
1X PM buffer containing 4 M glycerol (Carlo Erba) was prepared and stored at 4C. 
2.1.1.4. PM-8M Buffer 
1XPM buffer containing 8 M glycerol (Carlo Erba) was prepared and stored at 4C.                                                 
2.1.1.5. PMSF Solution 
200 mM PMSF (Sigma) was dissolved in isopropanol (Merck) up to 10 ml and 
stored at room temperature. 
2.1.2. Buffers for Ion-Exchange Column Purification 
2.1.2.1. 1X PM 
5X PM buffer was diluted with deionized water five times and pH was adjusted to 
6.9. 
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2.1.2.2. 1X PM with GTP and DTT 
0.1 mM GTP (Sigma) and 2 mM DTT (Sigma) were dissolved in 1X PM buffer up to 
100 ml and pH was adjusted to 6.9. 
2.1.2.3. NaOH Solution 
0.5 M NaOH (Riedel-de Haen) was dissolved in deionized water up to 1.5 lt. and 
stored at 4C. 
2.1.2.4. HCl Solution 
1.5 lt. 0.5 M HCl (37%) (Merck) was prepared and stored at 4C.  
2.1.3. Buffers for Experiments 
2.1.3.1. AB Buffer 
20 mM Pipes (Roche), 1 mM MgCl2 (Riedel-de Haen) and 1 mM EGTA (Sigma) 
were dissolved in deionized water up to 1 lt. and pH was adjusted to 6.9 with NaOH. 
It was stored at 4C. 
2.1.4. Solutions for SDS-PAGE (Sodium Dodecyl Sulfate – Polyacrylamide Gel 
Electrophoresis) 
2.1.4.1. Acrylamide Monomer Solution (30% T/ 2.7% Cbis) 
58.4 g Acrylamide (Sigma) and 1.6 g Bis-acrylamide (Sigma) were dissolved in 
deionized water up to 200 ml and stored in dark at 4C. 
2.1.4.2. 4X Running (Separating) Gel Buffer 
36.3 g Tris (Meck) was dissolved in deionized water up to 200 ml and pH was 
adjusted to 8.8 with HCl. It was stored at 4C. 
2.1.4.3. 4X Stacking Gel Buffer 
3 g Tris (merck) was dissolved in deionized water up to 50 ml and pH was adjusted 
to 6.8 and stored at 4C. 
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2.1.4.4. 10% SDS 
10 g SDS (99%) (Sigma) was dissolved in deionized water up to 100 ml and stored at 
room temperature. 
2.1.4.5. 10% Ammonium Persulfate (APS) 
0.1 g APS (Sigma) was dissolved in deionized water up to 1 ml and stored at 4C. 
APS has a two week life. 
2.1.4.6. TEMED (N, N, N’, N’ – Tetramethylethylene diamine) 
TEMED (Farmitalia Carlo Erba S.p.A.) was used as purchased. 
2.1.4.7. 2X Sample Buffer 
2.5 ml 4X Stacking Gel Buffer, 4 ml 10% SDS solution, 2 ml Glycerol (20% 
glycerol) (Carlo Erba), 1 ml - mercaptoethanol (Merck) and 0.05% Bromophenol 
Blue (BRB) (Sigma) were mixed with deionized water up to 10 ml. It was stored at -
20C as aliquots of 1.5 ml.   
2.1.4.8. Tank Buffer (Running Buffer)  
3 g/L Tris (Merck), 14.4 g/L Glycine (Merck) and 1 g/L SDS were dissolved in 
deionized water up to 1 lt. and stored at 4C. 
2.1.4.9. Coomassie Blue Stain 
0.1% CBB R-250 (Fluka) was dissolved in 1 lt. deionized water containing 50% 
Methanol (Merck) and 10% Acetic acid (Merck). It was stored at room temperature. 
2.1.4.10. Gel Destain 
50 ml (1:20) Methanol and 100 ml (1:10) Acetic acid were mixed with deionized 
water up to 1 lt. It was stored at room temperature. 
2.1.5. Stock Solutions 
2.1.5.1. GTP Stock 
200 mM GTP (Sigma) was dissolved directly in deionized water and stored at -20C 
as aliquots of 20 l. 
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2.1.5.2. DTT Stock 
1 M DTT (Sigma) was dissolved directly in deionized water and stored at -20C as 
aliquots of 1 ml. 
2.1.5.3. Taxol Stock 
10 mM Taxol (Paclitaxel, Sigma) was dissolved in DMSO (dimethyl sulfoxide) 
(Riedel-de Haen) and stored at -20C. 
2.1.5.4. Bisphenol A Stock 
Bisphenol A (BPA) (Sigma) (10 mM) was dissolved in DMSO (Riedel-de Haen) and 
stored at 4C. 
2.1.6. Cellulose Phosphate Resin 
Cellulose Phosphate Cation Exchanger (Whatman) was used for ion-exchange 
column preparation. 
2.1.7. Solutions for Determination of Protein Concentration 
2.1.7.1. Bradford Reagent 
Bradford Reagent (Sigma) was used as purchased. 
2.1.7.2. Bovine Serum Albumine (BSA) 
14.5 mg/ml BSA (Sigma) was dissolved in deionized water up to 10 ml and stock 
standard solutions were prepared from that. They were stored at -20C. 
2.1.8. Solutions for Electron Microscopy 
2.1.8.1. Pioloform  
250 mg Pioloform (Agar Scientific) was dissolved in 100 ml chloroform (Merck). It 
was waited at 4 C for 10 days before use and kept in dark place. 
2.1.8.2. Gluteraldehyde 
40 l Gluteraldehyde (Merck) was mixed with deionized water to make 4% (v/v) and 
stored at room temperature. 
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2.1.8.3. Uranyl Acetate  
Uranyl Acetate (Sigma) was dissolved in deionized water to make 2% (w/v) and 
stored at room temperature. 
2.1.9 Protein Marker  
Benchmark Prestained Protein Ladder (Gibco) was used as a standard to analyze the 
SDS-PAGE gels. It consists of 10 proteins ranging in molecular weights of 10, 15, 
20, 30, 40, 60, 70, 90, 130, and 220 kDa.  
2.1.10 Lab Equipment 
Autoclaves : 2540 ML Benchtop Autoclave, Systec   GmbH     
Labor-Systemtechnik. 
: NuveOT 4060 vertical steam sterilizer, Nuve. 
Balances  : Precisa BJ 610C, order# 160-9423-050, 
Precisa Instruments AG, Dietikon. 
: Precisa XB 220A, order# 320-9204-001, 
Precisa Instruments AG, Dietikon. 
Centrifuges     : Avanti J-30I, Beckman Coulter. 
     : Optima LE80K, Beckman Coulter. 
     : Optima Max, Beckman Coulter.  
     : Allegra 25R, Beckman Coulter. 
Centrifuge rotors    : JLA-16250, Beckman Coulter.  
     : 70Ti, Beckman Coulter. 
     : MLA 80, Beckman Coulter. 
     : TS-5.1-500, Beckman Coulter. 
Deep freezers and refrigerators  : 2031 D Deep Freezer, Arcelik. 
     7751 T, Beko. 
Electron Microscope  : JEM 1011 Transmission Electron Microscope, 
Joel. 
Electrophoresis equipments  : EC 120 Mini Vertical Gel System, ThermoEC. 
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Fluorescence Spectrometer  : LS-50, Perkin Elmer. 
Fraction Collector   : Model 2110, Bio-Rad. 
Gel documentation system   : UVIpro GAS7000, UVItec Limited.   
Gel dryer     : Model 583, Bio-Rad. 
Glassware     : Technische Glaswerke Ilmenau GmbH. 
Grids                                                 : 300 mesh size copper grids, Sigma.                                    
Homogenizator    : Potter S, B.Braun Biotech International 
Ice machine     : AF 10, Scotsman. 
Incubators     : EN400, Nuve.  
Laminar Flow Cabinet  : Ozge.  
Magnetic stirrer    : AGE 10.0164, VELP Scientifica srl.  
     : AGE 10.0162, VELP Scientifica srl. 
Microwave     : MD582, Arcelik. 
Peristaltic pump   : Bio-Rad. 
pH meters                                         : MP 220, Mettler Toledo International Inc. 
: Inolab pH level 1, order# 1A10-1113, 
Wissenschaftlich-Technische Werkstätten 
GmbH & Co KG. 
Pipettes     : 0.1-2.5, 500-5000, Mettler Toledo. 
     : 10, 20, 200, 1000, Gilson. 
Pipette tips    : 1-1000 l, 1-200 l Axygen. 
     : 1-10 l, Molecular Bioproducts. 
                                                           : Gel loading tip, 10 l, Molecular Bioproducts. 
Power supply    : EC 250-90, E-C Apparatus. 
Pure water systems                          : USF Elga UHQ-PS-MK3, Elga Labwater. 
Shaker     : Duomax 1030, Heidolph Instruments. 
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Spectrophotometers   :DU530 Life Science UV/Vis, Beckman. 
     : UV-1601,Shimadzu Corporation. 
     : Lambda 25 UV/Vis, Perkin Elmer. 
Test tubes     : 1.5 ml tubes, Eppendorph. 
Vacuum pump    : 262 BR, Bio-Rad. 
Vortexing machine    : Reax Top, Heidolph Instruments. 
Water bath     : Memmert. 
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2.2. Methods 
2.2.1. Tubulin Purification 
 One bovine brain was used for tubulin purification. 
 Cerebellum and meninges with blood vessels were removed. And the 
remaining brain was weighed. 
 The brain was minced with scissors. 
 For each 100 g of brain, 75 ml PM-4M buffer containing 1 mM PMSF and 1 
mM DTT was added into a blender and mixed. 
 The homogenate was centrifuged with Beckman Avanti J-30I centrifuge, 
JLA-16250 rotor, 250 ml tubes at 30,000 x g and 4°C for 30 minutes. 
 Supernatants were collected and centrifuged with Beckman Optima LE80K 
centrifuge, 70Ti rotor, 35 ml tubes, at 183,960 x g and 4°C for 40 minutes. 
 Supernatants were collected and the total volume was named as V1.  
 200 mM GTP was added and resulting mixture was incubated at 37° C for 30 
minutes. 
 The mixture was centrifuged with  Beckman Optima LE80K centrifuge, 70Ti 
rotor, 26.3 ml tubes, at 183,960 x g (and Beckman Optima Max 
Ultracentrifuge, MLA 80 rotor, 10 ml tubes, at 184,262 x g) at 37° C for 30 
minutes. 
 Supernatants were decanded and pellets were taken onto ice and resuspended 
with 0.25xV1 ml of 1xPM buffer containing 1 mM PMSF and 1 mM DTT. 
 The resuspended solution was homogenized with Potter S Homogenizator on 
ice and incubated at 4° C for 30 minutes. 
 The homogenate was centrifuged with Beckman Optima Max 
Ultracentrifuge, MLA 80 rotor, 10 ml tubes, at 184,262 x g and  4° C for 30 
minutes. 
 The supernatants were collected and named as V2. 
 Equal volume (V2) of PM-8M buffer was added; total volume= 2xV2. 
 1 mM PMSF, 1 mM DDT and 2 mM GTP were added into total volume. 
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 Mixture was incubated at 37° C for 30 minutes. 
 Mixture was centrifuged with Beckman Optima Max Ultracentrifuge, MLA 
80 rotor, 10 ml tubes, at 184,262 x g and 37° C for 30 minutes. 
 Supernatants were decanded and pellets were resuspended with 0.25x V2 ml 
of PM buffer. 
 The resuspended solution was homogenized with Potter S Homogenizator on 
ice and incubated at 4° C for 30 minutes. 
 The homogenate was centrifuged with Beckman Optima Max 
Ultracentrifuge, MLA 80 rotor, 10 ml tubes, at 184,262 x g and 4° C for 30 
minutes. 
 Supernatants were collected, named as semipurified tubulin and kept at -80° 
C as aliquots. 
 The concentration of tubulin protein was determined by Bradford Assay. 
2.2.2. Bradford Assay 
 14.5 mg Bovine Serum Albumin (BSA) was dissolved in 10 ml deionized 
water. 
 Stock standard solutions were prepared as containing concentrations of 20 
μg/ml, 40  μg/ml, 60 μg/ml, 80 μg/ml, 100 μg/ml, 120 μg/ml, 140 μg/ml, 160 
μg/ml, 180 μg/ml, 200 μg/ml, 220 μg/ml, 240 μg/ml, 260 μg/ml, 280 μg/ml 
and 300 μg/ml BSA. 
 From each stock standard  solution, 100 μl was added to tubes for standard 
preparation. 
 Then 900 μl Bradford reagent was added to each tube (total 1 ml). 
 Sample preparation: sample amount was completed with deionized water up 
to 100 μl. 
 Then 900 μl Bradford reagent was added to each tube (total 1 ml). 
 Blank solution was prepared to zero spectrophotometer: 100 l deionized 
water with 900 l Bradford reagent. 
 Both standard solutions and samples were transferred into spectrophotometer 
cuvettes just before measurement. 
 The absorbance values and protein concentrations were measured at 595 nm 
with Beckman DU530 UV/Vis Spectrophotometer. 
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2.2.3. Further Tubulin Purification 
2.2.3.1. Cellulose Phosphate Ion-Exchanger Column Preparation 
 The volume of glass column was measured and named as V. 
 V/4 g of phosphocellulose resin was weighed and  put into a beaker. 
 25xV/4 ml 0.5 M NaOH  was added and stirred gently, and left for 5 minutes. 
 The supernatant was decanded and washed with deionized water until the 
filtrate pH was 11.0 or below. 
 Then 25xV/4 ml 0.5 M HCl  was added and stirred kindly, and left for 5 
minutes. 
 The supernatant was decanded and washed with deionized water until the 
filtrate pH was 3.0 or above. 
 The supernatant was decanded completely and  25xV/4 ml 1x PM buffer was 
added. 
 The pH was adjusted to 6.9 with NaOH. 
 The resin was poured into the column. 
 When all slurry was added, the cap of the column was attached. 
 1x PM buffer was run through the column until the column bed height was 
constant. 
 150 ml 1x PM buffer containing 0.1 mM GTP and 2 mM DDT was run 
through the column. 
 The pH of the eluate was checked to be 6.9. 
 The column was left overnight at 4° C. 
 All these steps were completed at 4° C. 
2.2.3.2. Further Tubulin Purification 
 The fraction collector was attached with Bio-Rad peristaltic pump connected 
to the outlet of the column. 
 Certain amount of semipurified tubulin solution was loaded to the column. 
 Approximately V/2 ml of 1x PM buffer was run through the column with the 
flow rate of 2.5 ml/min. 
 1 to 12 fractions were collected as 2.5 ml and rest of the fractions were 
collected as 0.6 ml. 
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 10 μl samples were taken from each fraction and analyzed by Bradford 
reagent to determine which fractions contained protein. 
 The fractions containing protein were pooled and the concentration was 
measured by Bradford Assay. 
2.2.3.3. Elution of Microtubule-associated proteins from the column 
 After tubulin proteins were obtained, microtubule-associated proteins were 
eluted from the column. 
 200 ml 1X PM buffer containing 1 M NaCl was run through the column and 
the fractions were collected. 
 10 μl samples were taken from each fraction and analyzed by Bradford 
reagent to determine which fractions contained protein. 
 To determine the MAP fractions 7% SDS-PAGE gel was run and the 
fractions containing protein were pooled. 
 Then MAPs were centrifuged with Beckman Allegra 25R, TS-5.1-500 rotor, 
Amicon-Centriplus centrifugal filter devices at 1396 x g, at 4C for several 
hours. 
 The filtered buffer was decanded and centrifugation was continued until 
MAPs were concentrated to 1/5 of its starting volume. 
 MAPs were washed three times with 1X PM buffer to decant from salt. 
 Then MAPs were collected by centrifugation. 
 The concentration of MAPs was measured by Bradford Assay. 
2.2.4. Sedimentation Assay 
 Microtubule sedimentation assays were performed in AB buffer.  
 Tubulin proteins from -80 C were thawed on ice. 
 In a reaction volume of 100 L, tubulin (5 M final) or taxol-stabilized MTs 
(TMTs) were incubated with or without GTP (1 mM) in the presence of 
bisphenol A (BPA) with various concentrations (10, 50, 100, 200 μM). 
 Preparation of TMTs: tubulin (10 M) was incubated with GTP (1 mM) and 
taxol (100 M) at 37° C for 30 minutes. 
 BPA was dissolved in dimethyl sulfoxide. 
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 Control reactions contained no BPA.  
 Additional control reactions with DMSO (final concentration 0.05%) were 
performed.  
 After incubation for 30 minutes at 37° C, reactions were centrifuged at 
127,960 x g for 30 minutes at 37° C with Beckman Optima Max 
Ultracentrifuge.  
 The supernatants were transferred into tubes containing equal amounts of 2x 
SDS sample buffer, and the pellets were resuspended in 100 L of 1x SDS 
sample buffer.  
 Supernatant and pellet fractions were then analyzed by SDS-PAGE.  
 For quantitative analysis, the amount of supernatant and pellet samples 
loaded onto the gels was optimized to ensure a linear relationship between the 
amount of protein loaded and the intensity of the Coomassie blue stained 
protein bands.  
 The amount of MT proteins in the supernatant and the pellet fractions was 
quantified by mesuring the protein band intensities relative to standards with 
UVIpro GAS7000 Gel Documentation and Analysis System, Quantification 
Analysis UVITech UVIBand Map V99.01 Software.  
2.2.5. SDS-PAGE 
 Supernatants and pellets were separated. 
 For each 100 μl of supernatant, 100 μl 2x sample buffer was added and mixed 
with vortex. 
 For each pellet, 100 μl 1x sample buffer was added and mixed with vortex. 
 5 μl samples from pellet solutions and 10 μl samples from supernatant 
solutions were loaded onto SDS-PAGE gels using micropipette and loading 
tips. 
2.2.5.1. Assembly of Gel  
 Glass plates and spacers were cleaned with ethanol. 
 They were assembled in gel holder on casting stand. 
 Upper and lower screws were tightened and bottom edges of gel plates were 
checked. 
 40 
 Smaller plate was marked 1.5 cm from top. 
2.2.5.2. %10 Running (Separating) Gel Preparation 
 1.67 ml %30 acrylamide, 1.25 ml 4x running gel buffer, 1.97 ml deionized 
water, 50 μl %10 SDS, 30 μl %10 APS and 10 μl TEMED were mixed and 
poured between the glass plates up to the mark. 
 When the gel was polymerized, the top of the gel was rinsed with tank buffer. 
 Remaining water was absorbed with filter paper. 
2.2.5.3. %4 Stacking Gel Preparation 
 0.27 ml %30 acrylamide, 0.5 ml 4x stacking gel buffer, 1.9 ml deionized 
water, 20 μl %10 SDS, 10 μl %10 APS and 5 μl TEMED were mixed and 
poured onto the running gel to the top of the front plate. 
 A comb was placed into the stacking gel quickly. 
 Gel was left for polymerization. 
 After polymerization the comb was removed carefully. 
 Lanes were washed with tank buffer and dried with filter paper. 
 5 μl samples from pellet solutions and 10 μl samples from supernatant 
solutions were loaded onto SDS-PAGE gels using micropipette and loading 
tips. 
 Gel was run at 200 mV for approximately 45 minutes with E-C Apparatus 
Corporation, EC 250-90 power supply. 
 Then the glass plates were separated and the gel was placed in Coomassie 
Blue stain in a clean box. 
 The gel was microwaved at 750 Watt for 40 seconds. 
 Then the gel was placed on shaker for 2 minutes. 
 The stain was poured off and the gel was rinsed with gel destain.  
 The gel was covered with gel destain and microwaved at 750 Watt for 50 
seconds. 
 It was placed on shaker for 15 minutes. 
 Then destain was poured off and replaced with fresh destain solution. 
 It was left overnight on shaker. 
 The gel was dried with Bio Rad Model 583 Gel Dryer for storage. 
 41 
 After scanning of dry gel, it was analysed with UVIpro GAS7000 Gel 
Documentation and Analysis System, Quantification Analysis UVITech 
UVIBand Map V99.01 Software. 
2.2.6. Fluorescence Spectrometry 
 Spectrometric mesurements were performed in AB buffer using the Model 
LS-50 spectrometer of Perkin-Elmer, equipped with a temperature controller.  
 In a reaction volume of 3 ml, tubulin (10 M) protein was mixed with BPA 
(200 M) and GTP (1mM).  
 Samples were excited at 295 nm and variation in the fluorescence spectra and 
emission intensity of the tryptophan residues in tubulin were monitored at 
336 nm as a function of polymerization time during 1 hour incubation at 
37°C. 
 Control reactions were performed without BPA. 
2.2.7. Electron Microscopy 
2.2.7.1. Reaction Conditions 
Control 1: 10 μM semi-purified tubulin + 5 mM GTP + 100 μM Taxol 
Control 2: 10 μM semi-purified tubulin + 5 mM GTP  
Reaction 1: 10 μM semi-purified tubulin + 5 mM GTP + 100 μM Taxol + 100 μM 
BPA 
Reaction 2 : 10 μM semi-purified tubulin + 5 mM GTP + 100 μM BPA 
2.2.7.2. Coating Grids with Pioloform 
 Grids were put into 100% ethanol then chloroform before use then left for 
drying. 
 Pioloform (250 mg) was dissolved in chloroform (100 ml). It was waited at 
4 C for 10 days before use and kept in dark place. 
 A glass block was plunged into pioloform solution and pulled out. Then it 
was left for drying in upright position approximately 2 min. 
 The edges of the film on glass block were cut with a razor. 
 The glass block was plunged into clean water and the film was left on water. 
 Grids were put on the swimming film as their bright sides on the top. 
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 A clean slide was come near to the film and covered on it. Therefore, film 
covered grids were adhered to the slide. 
 The slide was put into a clean dish and waited at 37 C for 1 day. 
2.2.7.3. Preparation of Electron Microscopy Grids 
 Polymerization of microtubules were carried out with freshly thawed 
microtubule proteins.  
 All reactions were completed with AB buffer up to 100 l in 1.5 ml test 
tubes. 
 The tubes were incubated at 37° C in water bath for 1 hour. 
 They were centrifuged with Beckman Optima Max Ultracentrifuge, MLA-80 
rotor, at 127,960 x g, 37° C for 30 minutes. 
 The supernatants were decanded. 
 20 μl 4% gluteraldehyde was added onto pellets and left for 15 minutes for 
fixation. 
 Pellets were resuspended with micropipette one or two times gently. 
 Grids were plunged into tubes and waited for 20 seconds. 
 Then grids were washed by plunging into distilled water three times. 
 Grids were left for air-dry for 30 minutes and stained. 
2.2.7.4. Staining 
 One drop of 2% uranyl acetate for each grid was put onto parafilm. 
 Grids were placed on drops upside down and left for 2 minutes. 
 Grids were washed by plunging into distilled water two times. 
 Excess water was removed with filter paper. 
 Grids were left for air-dry. 
 Grids were analyzed with Joel Jem 1011 Transmission Electron Microscope. 
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3. RESULTS AND DISCUSSION 
The aim of this study is to investigate the effects of BPA, an environmental estrogen, 
on cytoskeletal proteins, primarily on microtubules. For this reason, microtubules 
were purified from bovine brain with two cycles of polymerization and 
depolymerization method. Then, a further purification was performed with the 
phospho-cellulose ion-exchange column to obtain pure tubulin protein without 
microtubule-associated proteins (MAPs).  
To analyze the effects of BPA on microtubule assembly and disassembly dynamics, 
we have employed sedimentation assays, fluorescence spectroscopy and electron 
microscopy experiments. 
3.1. Tubulin Purification 
A fresh bovine brain from butchery was taken to the laboratory immediately on ice. 
The cerebellum and meninges with blood vessels were removed. The remaining parts 
were weighed and the tubulin purification procedure was performed according to two 
cycles of polymerization and depolymerization method as mentioned before. At the 
end of this preparation, tubulin proteins were obtained together with microtubule 
associated proteins (MAPs) and called ‘semi-purified tubulin’. Then, the protein 
concentration was determined by the Bradford protein assay using bovine serum 
albumin (BSA) as a standard. To observe the purification steps, samples from each 
fraction of the procedure were run on an SDS-polyacrylamide gel (Figure 3.1).  
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MAPs bind to polymerized microtubules or unpolymerized tubulins. This binding 
speeds up polymerization, facilitates assembly and stabilizes microtubules. To 
separate tubulin proteins from MAPs, phospho-cellulose ion-exchange column was 
prepared. Ion-exchange column purification separates molecules based on 
differences between the charge of the proteins. The phospho-cellulose column used 
in this purification was a cation column. In a cation exchange separation, positively 
charged proteins bind to the stationary phase in the column. Since MAPs are 
positively charged, they remained in the column attached to the resin and negatively 
charged tubulin proteins passed through the column.  
Certain amount of semi-purified tubulin was loaded to the column and then PM 
buffer was run through. All the fractions collected were qualitatively analyzed with 
Bradford reagent for the presence of tubulin protein. Bradford reagent contains 
Coomassie Brilliant Blue G-250 dye which binds to proteins. This binding of CBB 
G-250 causes a color change indicating the presence of the protein. The fractions 
which contained color change were pooled into a tube. First, an SDS-PAGE (10%) 
was run to ensure whether or not fractions include any MAPs. After the column 
purification, one tubulin fraction could be seen free of MAPs. Also pure tubulin 
(99%) purchased from Cytoskeleton was run on the gel as a standard (Figure 3.2). 
 
 
Figure 3.1. Tubulin purification fractions after two cycle of polymerization and depolymerization 
procedure. M, protein marker; 1, first depolymerization supernatant; 2, first polymerization 
supernatant; 3, first polymerization pellet; 4, second depolymerization supernatant; 5, second 
depolymerization pellet; 6, second polymerization supernatant; 7, second polymerization pellet; 8,  
third depolymerization supernatant; 9, third depolymerization pellet; 10, tubulin. 
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3.1.1. Elution of MAPs from phospho-cellulose column 
While negatively charged tubulin proteins passed through the phospho-cellulose 
column, positively charged MAPs were bound to the resin. To elute MAPs from the 
column, PM buffer containing 1 M NaCl was run through. The eluted buffer which 
contained MAPs was collected as fractions. Small amounts of Bradford reagent was 
added into samples from these fractions to detect the presence of proteins. Then, 
samples from some fractions that contain protein were run on an SDS-
polyacrylamide gel (Figure 3.3). 
 
 
 
 
Figure 3.2. Semi-purified tubulin and purified tubulin after column purification. Each tubulin monomer 
(/) has a molecular weight of 55 kDa. The first fraction containig semi-purified tubulin with MAPs 
fractions can be seen. The second fraction is purified tubulin that was obtained after column purification 
(free of MAPs). The third fraction belongs to pure tubulin (99%) which was purchased from 
Cytoskeleton. 
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Then MAPs were concentrated about five fold with Amicon-Centriplus centrifugal 
filter devices using Beckman Allegra 25R centrifuge. The concentration of MAPs 
were determined by Bradford assay using BSA as a standard. 
3.2. Sedimentation Assays 
To analyze the effects of BPA on microtubule polymerization, we have employed a 
microtubule sedimentation assay. Tubulin proteins from -80 C were first thawed on 
ice. In this assay, either semi-purified (spTb) or purified tubulin (pTb) proteins were 
used. In a reaction volume of 100 l, tubulin proteins (final concentration 5 M) and 
BPA (200 M)  were mixed in AB buffer (20 mM Pipes, 1 mM MgCl2 and 1 mM 
EGTA). GTP (1 mM) was added to the reactions of pTb. Control experiments were 
performed without BPA. Since BPA was dissolved in dimethyl sulfoxide (DMSO), 
additional control reaction mix with DMSO were also performed. The final 
proportion of DMSO in the reactions was 0.05%. After reactions were set, the tubes 
were incubated at 37 C for 30 minutes. Then, they were centrifuged at 127,960 x g 
(50,000 rpm), at 37 C for 30 minutes with Beckman Optima Max Ultracentrifuge. 
The principle of the sedimentation assay is based on the microtubule polymerization. 
When microtubules are centrifuged above 100,000 x g, polymerized microtubules 
precipitate in the pellet and unpolymerized tubulin subunits remain in the 
supernantant. After centrifugation, supernatants and pellets were separated and 
supernatants were transferred into other tubes containing equal amounts of 2x SDS 
sample buffer. Pellets were resuspended with 100 l of 1x SDS sample buffer. Both 
fractions were run on 10% SDS-PAGE. For quantitative analysis, the amount of 
supernatant and pellet samples loaded onto the gels were optimized to ensure a linear 
Figure 3.3. SDS-PAGE gel showing several MAP fractions. 
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relationship between the amount of protein loaded and the intensity of the Coomassie 
blue stained protein bands. The amount of microtubule proteins in the supernatant 
and in the pellet fractions were quantified by measuring the protein band intensities 
relative to standards with UVIpro GAS7000 Gel Documentation and Analysis 
System, Quantification Analysis UVITech UVIBand Map V99.01 Software. To 
compare the amount of protein in all fractions, we prepared protein standards which 
contained 1, 3, and 5 M tubulin. 
Sedimentation experiments with spTb were performed with various concentrations of 
BPA (10, 50, 100, 200 M) to get the dose-response results and the effective BPA 
concentration. The densities of the pellet fractions in BPA-treated reactions were 
lower than the density of pellet fraction in control reaction. The SDS-PAGE results 
indicated that formation of microtubules from spTb was inhibited at 37C in the 
presence of BPA (Figure 3.4).  
The inhibition of microtubule polymerization caused by BPA was observed in a 
dose-dependent manner (Figure 3.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4. Effects of various doses of BPA on microtubule polymerization on the same SDS-
polyacrylamide gel. 
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In the experiments with spTb, SDS-PAGE showed the decrease in the density of 
pellet fractions and the increase in the density of supernatant fractions in the presence 
of 200 M BPA indicating inhibition of microtubule polymerization (Figure 3.6).   
 
 
 
 
  
 
 
 
 
 
 
 
 
 
During the sedimentation experiments with spTb, GTP was not used; since MAPs 
already facilitate microtubule assembly and stabilizes assembled microtubules. In in 
vitro conditions, GTP is not needed in the case of MAP-assembled microtubules, but 
purified tubulin proteins are separated from MAPs; therefore, GTP is needed to 
facilitate the polymerization of microtubules at 37C in vitro.   
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Figure 3.5. Dose-response graph of inhibition of microtubule polymerization caused by BPA. 
Figure 3.6. SDS-polyacrylamide gel of 5 M spTb with or without 200 M BPA.  
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BPA was dissolved in DMSO, so additional control experiments were carried out 
with DMSO. DMSO also showed some inhibitory effects on microtubule 
polymerization compared to the control reactions. But with 200 M BPA, inhibition 
of polymerization was more significant compared to control and DMSO reactions. 
These suggest that BPA effects are dependent on its accumulation, hence BPA shows 
its effects in a dose-dependent manner. 
To investigate the effects of BPA on polymerized microtubules, we stabilized 
microtubules with taxol (taxol-stabilized microtubules - TMTs). TMTs were 
prepared as following: tubulin proteins (10 M final concentration) were put in 100 
l AB buffer containing 1 mM GTP and 100 M taxol, and then incubated at 37 C 
for 30 minutes. In the sedimentation assay, the final concentration of TMTs was 5 
M in the AB buffer containing 200 M BPA. Control reactions were performed 
without BPA. The reaction tubes were incubated either at room temperature (RT) or 
at 37 C for 30 minutes. After incubation, the tubes were centrifuged at 127,960 x g 
(50,000 rpm), at 37  C  for 30 minutes with Beckman Optima Max Ultracentrifuge. 
Supernatants and pellets were separated and samples were prepared for SDS-PAGE 
as mentioned before. Then, the fractions on the gel were analyzed quantitatively with 
Gel Documentation System. TMTs were prepared from either semipurified or 
purified tubulins.  
The results showed that BPA depolymerized assembled microtubules at 37 C, but 
not at RT. These are indicated by the decrease in the density of pellet fractions and 
the increase in the density of supernatant fractions in BPA-treated reactions 
compared to control reactions (Figure 3.7). 
However, the depolymerization effects that were obtained were not as significant 
with pTb or purified TMTs. In the experiments with pTb, SDS-polyacrylamide gels 
showed that the density of the pellet fractions of BPA-treated reaction is lower than 
the pellet of the control reaction (Figure 3.8). 
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Figure 3.8. SDS-polyacrylamide gel of 5 M pTb with or without 200 M 
BPA. 
Figure 3.7. SDS-polyacrylamide gel of semi-purified TMT with or without BPA at RT and 
37C. 
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Also, SDS-PAGE of purified TMTs did not show significant difference between 
BPA-treated and control reactions (Figure 3.9). These result may suggest that BPA 
shows its effect through MAPs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3. Fluorescence Spectrometry Results 
Luminiscence is the emission of photons from electronically excited states. 
Fluorescence is the emission which results from the return to the lower orbital of the 
paired electron. Fluorescence data are generally presented as emission spectra. An 
emission spectrum is the wavelength distribution of the emission, measured with a 
single constant excitation wavelength. Such spectra can be presented on either a 
wavelength scale or a wave number scale. The usual units for wavelength are 
nanometers, and wave numbers are given in cm-1. An excitation spectrum is the 
dependence of emission intensity at a single wavelength, upon the excitation 
wavelength. Briefly, the emission spectra represent the photon flux emitted at each 
wavelength and the excitation spectra represent the relative quantum yields at 
excitation wavelength. Corrected spectra are needed for calculation of quantum 
yields and overlap integrals. 
The emission spectra vary widely and are dependent upon the chemical structure of 
the fluorophore and the solvent in which it is dissolved. Also solvent effects, solvent 
Figure 3.9. SDS-polyacrylamide gel of purified TMTs with or without BPA at RT and 
37 C.  
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relaxation, quenching and a variety of excited state reactions can influence the 
fluorescence emission. 
Fluorescence quenching refers to any process which decreases the fluorescence 
intensity of a given substance. If a given solvent is very viscous, then the diffusion is 
slow and the quenching is inhibited. 
Fluorescence methods are useful tools for studying the structure and dynamics of 
living systems, proteins, membranes and their interactions with other 
macromolecules. A variety of biological molecules contain naturally occurring or 
intrinsic probes or fluorophores.  
Tryptophan is the most highly fluorescent amino acid in proteins. The tryptophan 
residues of proteins generally account for about 90% of the total fluorescence from 
proteins. This natural fluorophore is highly sensitive to the polarity of its surrounding 
environment. Tryptophan appears to be sensitive to quenching by a variety of 
substances and this sensitivity allows determination of the accessibility of the 
tryptophan residues in proteins by quenching measurements. Upon excitation at 295 
nm, only tryptophan fluorescence is seen. 
Tubulin dimers in microtubules contain eight tryptophan residues. The tryptophans 
are arranged linearly along the long axis of the dimer within 2 nm distance of each 
other. The indole nucleus of these residues is a uniquely sensitive and complicated 
fluorophore. Changes in the fluorescence of tryptophan residues can be used to 
monitor structural transitions by a  fluorescence spectrometer. When microtubules 
are depolymerized to tubulin monomers, tryptophan residues are exposed to the 
aqueous solvent. Because when depolymerization occurs, tryptophan residues in 
tubulin dimers become free in the solution, and then, they transfer their energy by 
vibrating in the environment; hence, the emission spectrum decreases. However, 
polymerization of tubulin dimers causes stabilization of tryptophan amino acids in 
the polymer and tryptophan residues fluoresce. This structural transition results in the 
increased emission spectrum. Tryptophan gives maximum emission intensity at 336 
nm when excited at 295 nm.  
We compared fluorescence intensities of tryptophan residues of tubulin either in the 
presence or in the absence of BPA to determine the effect of BPA on microtubule 
polymerization. 
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In this experiment, either purified or semi-purified tubulin proteins were used. The 
final concentration of tubulin proteins was 10 M in AB buffer containing 1 mM 
GTP and 200 M BPA. Control reactions were performed without BPA. Samples 
were first excited at 295 nm. Variation in the fluorescence spectra and emission 
intensity of the tryptophan residues in tubulin were monitored at 336 nm as a 
function of polymerization. The measurements were performed per 2 minutes during 
1 hour incubation at 37° C.  
In the experiments with semi-purified tubulin, BPA caused an increase in the 
scattered light indicating microtubule depolymerization (Figure 3.10). 
 
 
 
 
Corrected emission intensities which were calculated according to the division of 
emission intensity to the scattered light degree showed a decrease in the presence of 
BPA which is correlated with the depolymerization of microtubules (Figure 3.11). 
 
 
 
 
 
Figure 3.10.  Comparison of scattered light values of control and BPA-treated semi-purified 
tubulins. 
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A decrease in the emission spectrum is expected when microtubules are 
depolymerized. In contrast to emission spectrum, scattered light should increase 
during depolymerization. Either viscosity or turbidity of the environment affects the 
emission spectrum primarily. These factors increase the emission intensity. During 
microtubule polymerization, both viscosity and turbidity of the solution increases; 
hence, the emission spectrum increases. Corrected emission spectrum was calculated 
by dividing the emission intenstiy to the scattered light degree. Corrected spectrum 
values were decreased in BPA-exposed reactions compared to the control reactions 
suggesting the inhibition of microtubule polymerization. 
Since the results of sedimentation assays suggested the effect of BPA through MAPs, 
in the fluorescence spectroscopy experiments with pTb, MAPs were added into the 
reaction mix at a certain time point. Figure 3.12 shows the comparison of corrected 
emission spectra between the control and BPA-treated reactions in the presence of 
MAPs. Corrected emission spectrum values were decreased in the presence of BPA 
and this indicates the inhibition of microtubule polymerization. This result also 
suggests that BPA shows its effect through MAPs.    
 
 
Figure 3.11. Comparison of corrected emission spectra of control and BPA-treated 
semi-purified tubulins. 
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3.4. Electron Microscopy Results 
Electron microscope allows us to determine the internal structure of both biological 
and non-biological samples. The principle of transmission electron microscopy 
(TEM) is based on the transmission of electron beam through the specimen. The 
darker areas of the image represent those areas of samples that fewer electrons were 
transmitted through (they are thicker or denser). The lighter areas of the image 
represent those areas of the sample that more electrons were transmitted through 
(they are thinner or less dense). 
To visualize the morphology of microtubules and the changes in the structure of 
microtubules when treated with BPA and support the results that we gained with in 
vitro experiments, we performed electron microscopy experiments.  
In electron microscopy experiments, either semi-purified tubulin proteins or  TMTs 
from semi-purified tubulins were used. 10 M tubulin or 10 M TMTs were 
incubated with 5 mM GTP and 100 M BPA at 37 C for 1 hour. Control reactions 
were performed without BPA. After incubation, the tubes were centrifuged with 
Beckman Optima Max Ultracentrifuge, at 127,960 x g (50,000 rpm), 37° C for 30 
minutes. The supernatants were decanded. 20 l 4% gluteraldehyde was added onto 
Figure 3.12. Comparison of corrected emission spectra of control and BPA-treated 
purified tubulin in the presence of MAPs. 
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pellets and left for 15 minutes for fixation. The samples were adsorbed to pioloform 
coated electron microscope grids by inserting grids into resuspended pellets in the 
tubes for 20 seconds. Then, grids were washed by plunging into distilled water three 
times and left for air-dry for 30 minutes and negatively stained with 2% uranyl 
acetate. 
In trial assays, reliable results with semi-purified tubulin could not be obtained. 
Microtubules are not resistant to harsh conditions such as grid preparation, staining 
and washing procedures; hence, they could depolymerize.   
However, taxol-stabilized microtubules (TMTs) were visualized as long cylindrical 
structures in control experiments (Figure 3.13). Since taxol stabilizes microtubules, 
TMTs are may not affected by the preparation steps.  
 
 
   
 
 
 
 
 
 
 
 
 
 
BPA caused different microtubule structures such as rings or spiral, relaxed 
structures consistent with depolymerization of microtubule structure and 
disintegration (Figure 3.14). 
 
 
 
 
 
 
Figure 3.13. Electron micrographs of taxol-stabilized microtubules (TMTs) (control).  
A) 50,000x, B) 100,000x  
A) B) 
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Figure 3.14. Electron micrographs of microtubules when treated with 100 M BPA (x50,000). 
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4. CONCLUSIONS 
Microtubules are cytoskeletal elements in all eukaryotic cells that are necessary for 
many functions including intracellular transport, morphogenesis, motility and cell 
division. In previous studies, BPA has been reported to disrupt the cytoplasmic 
microtubule complex and mitotic spindle in cultured cells. It induces metaphase 
arrest and micronuclei containing chromosomes. In addition to its estrogenicity, BPA 
acts as an aneuploidogen. This potential is possibly based on the interaction with 
microtubules. Our study indicates that BPA interacts with microtubules and disrupts 
microtubule formation under cell-free conditions. BPA inhibits microtubule 
polymerization in a concentration-dependent manner. BPA depolymerizes taxol-
stabilized microtubules. BPA causes abnormal microtubule structure such as spiral, 
relaxed and disintegrated microtubules consistent with depolymerization. The 
experimental results also suggest that BPA may show its effects on microtubules 
through microtubule-associated proteins. This needs to be further investigated. 
Further research involving analysis of effects of BPA on microtubule associated 
proteins will help to understand the exact molecular mechanism of BPA toxicity. 
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